🔎 Trials Near Me

Utama › Penyakit Crohn › Illinois › Chicago

Kajian klinikal Penyakit Crohn di Chicago, IL

9 kajian untuk Penyakit Crohn sedang mencari peserta di lokasi dalam dan sekitar Chicago (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)

Mengambil pesertaFasa 3
  • University of Chicago Medical Center ( Site 5066), Chicago
Umur 16 hingga 80 · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06430801

Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease

Mengambil pesertaFasa 2
  • University of Chicago Medical Center /ID# 267400, Chicago
Umur 18 hingga 75 · Semua jantina · Dikemas kini 25 Sep 2026 · NCT06548542

Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight

Mengambil pesertaFasa 3
  • Rush University Medical Center, Chicago
Umur 18 hingga 70 · Semua jantina · Dikemas kini 24 Sep 2026 · NCT06937099

An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease

Mengambil pesertaFasa 3
  • Rush University Medical Center-Site Number: 8400015, Chicago
Umur 16 hingga 80 · Semua jantina · Dikemas kini 23 Sep 2026 · NCT07184931

A Master Protocol (IIBD): A Study of Multiple Drugs in Adults With Ulcerative Colitis or Crohn's Disease

Mengambil pesertaFasa 2
  • Rush University Medical Center, Chicago
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07483073

A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease

Mengambil pesertaFasa 2
  • Rush University Medical Center, Chicago
Umur 18 hingga 80 · Semua jantina · Dikemas kini 22 Sep 2026 · NCT07483099

A Study of Vedolizumab Intravenous (IV) and Adalimumab or Vedolizumab and Ustekinumab in Adults With Crohn's Disease

Mengambil pesertaFasa 4
  • University of Chicago Medicine, Chicago
Umur 18 hingga 70 · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06045754

Treat-to-Target of Endoscopic Remission in Patients With IBD in Symptomatic Remission

Mengambil peserta
  • University of Chicago Medicine, Chicago
Umur 18 ke atas · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT05230173

Treatment of Moderate to Severe Refractory Crohn's Disease

Mengambil pesertaFasa 1/2
  • Northwestern, Chicago
  • University of Chicago, Chicago
Umur 18 hingga 65 · Semua jantina · Dikemas kini 10 Dis 2025 · NCT06721962

Kajian Penyakit Crohn di bandar lain

Kajian lain di Chicago

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.